This study investigates the effectiveness and safety of an investigational treatment for people aged 12 and older with moderate-to-severe atopic dermatitis (AD). Participants must have had an inadequate response to previous biologic therapy or an oral JAK inhibitor. The study involves using a subcutaneous solution alongside topical corticosteroids.The purpose is …
